Literature DB >> 32683175

Insights and perspectives on calcium channel functions in the cockpit of cancerous space invaders.

Sabrina Leverrier-Penna1, Olivier Destaing2, Aubin Penna3.   

Abstract

Development of metastasis causes the most serious clinical consequences of cancer and is responsible for over 90 % of cancer-related deaths. Hence, a better understanding of the mechanisms that drive metastasis formation appears critical for drug development designed to prevent the spread of cancer and related mortality. Metastasis dissemination is a multistep process supported by the increased motility and invasiveness capacities of tumor cells. To succeed in overcoming the mechanical constraints imposed by the basement membrane and surrounding tissues, cancer cells reorganize their focal adhesions or extend acto-adhesive cellular protrusions, called invadosomes, that can both contact the extracellular matrix and tune its degradation through metalloprotease activity. Over the last decade, accumulating evidence has demonstrated that altered Ca2+ channel activities and/or expression promote tumor cell-specific phenotypic changes, such as exacerbated migration and invasion capacities, leading to metastasis formation. While several studies have addressed the molecular basis of Ca2+ channel-dependent cancer cell migration, we are still far from having a comprehensive vision of the Ca2+ channel-regulated mechanisms of migration/invasion. This is especially true regarding the specific context of invadosome-driven invasion. This review aims to provide an overview of the current evidence supporting a central role for Ca2+ channel-dependent signaling in the regulation of these dynamic degradative structures. It will present available data on the few Ca2+ channels that have been studied in that specific context and discuss some potential interesting actors that have not been fully explored yet.
Copyright © 2020 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Calcium channels; Cancer; Invadopodia; Invadosome; Invasion; PIEZO; Podosome; STIM/Orai; TRPM7; TRPV2; TRPV4

Mesh:

Substances:

Year:  2020        PMID: 32683175     DOI: 10.1016/j.ceca.2020.102251

Source DB:  PubMed          Journal:  Cell Calcium        ISSN: 0143-4160            Impact factor:   6.817


  7 in total

Review 1.  Mechanisms and roles of podosomes and invadopodia.

Authors:  Stefan Linder; Pasquale Cervero; Robert Eddy; John Condeelis
Journal:  Nat Rev Mol Cell Biol       Date:  2022-09-14       Impact factor: 113.915

Review 2.  Science CommuniCa2+tion Developing Scientific Literacy on Calcium: The Involvement of CRAC Currents in Human Health and Disease.

Authors:  Christina Humer; Sascha Berlansky; Herwig Grabmayr; Matthias Sallinger; Andreas Bernhard; Marc Fahrner; Irene Frischauf
Journal:  Cells       Date:  2022-06-05       Impact factor: 7.666

Review 3.  Tumor Cellular and Microenvironmental Cues Controlling Invadopodia Formation.

Authors:  Ilenia Masi; Valentina Caprara; Anna Bagnato; Laura Rosanò
Journal:  Front Cell Dev Biol       Date:  2020-10-15

4.  Supra-Molecular Assemblies of ORAI1 at Rest Precede Local Accumulation into Puncta after Activation.

Authors:  Diana B Peckys; Daniel Gaa; Dalia Alansary; Barbara A Niemeyer; Niels de Jonge
Journal:  Int J Mol Sci       Date:  2021-01-14       Impact factor: 5.923

5.  Lamin B1 is a potential therapeutic target and prognostic biomarker for hepatocellular carcinoma.

Authors:  Yongyu Yang; Lei Gao; Junzhang Chen; Wang Xiao; Ruoqi Liu; Heping Kan
Journal:  Bioengineered       Date:  2022-04       Impact factor: 6.832

Review 6.  Advances in the study of cancer metastasis and calcium signaling as potential therapeutic targets.

Authors:  Chaochu Cui; Yongxi Zhang; Gang Liu; Shuhong Zhang; Jinghang Zhang; Xianwei Wang
Journal:  Explor Target Antitumor Ther       Date:  2021-06-28

Review 7.  T-Type Calcium Channels: A Mixed Blessing.

Authors:  Dario Melgari; Anthony Frosio; Serena Calamaio; Gaia A Marzi; Carlo Pappone; Ilaria Rivolta
Journal:  Int J Mol Sci       Date:  2022-08-31       Impact factor: 6.208

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.